Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Positron emission tomography in the lung.

J M Hughes, L H Brudin, S O Valind

    Journal of Thoracic Imaging
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pulmonary beta adrenoceptor density in arrhythmogenic right ventricular cardiomyopathy and idiopathic tachycardia.

    Basic research in cardiology·2001
    Same author

    Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography.

    Circulation·2000
    Same author

    Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo.

    European journal of pharmacology·2000
    Same author

    Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography.

    European journal of nuclear medicine·2000
    Same author

    Parametric polar maps of regional myocardial beta-adrenoceptor density.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1999
    Same author

    Variability of the lumped constant for [18F]2-deoxy-2-fluoroglucose and the experimental isolated rat heart model: clinical perspectives for the measurement of myocardial tissue viability in humans.

    Circulation·1999

    Positron emission tomography (PET) with the ECAT II scanner quantifies regional lung structure and function. This imaging technique offers insights into various lung diseases, paving the way for improved diagnostics and treatment strategies.

    Area of Science:

    • Pulmonary Medicine
    • Nuclear Imaging
    • Medical Physics

    Background:

    • Assessing regional lung function is crucial for diagnosing and managing respiratory diseases.
    • Traditional imaging methods have limitations in providing comprehensive functional and structural data.
    • Positron emission tomography (PET) offers a non-invasive approach to quantitative physiological measurements.

    Purpose of the Study:

    • To outline the use of Positron Emission Tomography (PET) with the ECAT II scanner for imaging and measuring regional lung function.
    • To demonstrate the capability of combined transmission and emission imaging for quantitative assessment.
    • To present clinical applications and future prospects of PET in pulmonary medicine.

    Main Methods:

    • Utilized the ECAT II scanner for Positron Emission Tomography (PET).

    Related Experiment Videos

  • Employed combined transmission and emission imaging techniques.
  • Quantified regional lung structure (density, extravascular density, vascular volume) and function (ventilation, perfusion, ventilation-perfusion ratios, glucose metabolic rate).

    • Main Results:

    • Demonstrated the ability of PET to provide quantitative data on regional lung structure and function.
    • Successfully imaged and measured parameters like ventilation, perfusion, and metabolic rate.
    • Established the utility of PET in evaluating diverse pulmonary conditions.

    Conclusions:

    • PET imaging with the ECAT II scanner is a valuable tool for quantitative assessment of regional lung structure and function.
    • The technique has broad clinical applications in various lung diseases, including asthma, COPD, and cancer.
    • Future advancements in PET technology hold promise for further enhancing pulmonary diagnostics and research.